Approval · Notice of Compliance 5292 · 1995
VERAPAMIL: Notice of Compliance 5292
Issued September 8, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5292
- Date
- September 8, 1995
- Company
- DispensapharmKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antianginal, antiarrhythmic, antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VERAPAMIL | 02178745 | — |
| VERAPAMIL | 02178753 | — |
| VERAPAMIL | 02178761 | — |
| VERAPAMIL | 02178788 | — |
| VERAPAMIL | 02179652 | — |
Medicinal ingredients
- VERAPAMIL HCL 80 MG per TAB
- VERAPAMIL HCL 120 MG per TAB
- VERAPAMIL HCL 180 MG per TAB
- VERAPAMIL HCL 240 MG per TAB